1 |
Baclofen
| 1件: Baclofen Baclofen | 2件: BACLOFEN BACLOFEN; Kemstro; | 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 |
2 |
Botulinum toxin type A
| 1件: Botulinum toxin type A Botulinum toxin type A | 8件: BOTOX BOTOX; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; | 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 13件: 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
3 |
Flunarizine hydrochloride
| 1件: Flunarizine Flunarizine | 0件: | 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
4 |
Sodium oxybate
| 1件: Sodium oxybate Sodium oxybate | 1件: Sodium Oxybate Sodium Oxybate; | - | - | 2件: 6 6, 149 |
5 |
Lacosamide
| 1件: Lacosamide Lacosamide | 1件: Lacosamide Lacosamide; | 2件: SCN3A SCN3A, SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 3件: 2 2, 46, 149 |
6 |
Fenfluramine
| 1件: Fenfluramine Fenfluramine | 2件: Fenfluramina Fenfluramina; Fenfluramine; | 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 140 140, 144, 145, 149 |
7 |
Flunarizine
| 1件: Flunarizine Flunarizine | 0件: | 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
8 |
Melatonin
| 1件: Melatonin Melatonin | 2件: Circadin Circadin; Melatonin; | 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
9 |
Brivaracetam
| 1件: Brivaracetam Brivaracetam | 1件: Brivaracetam Brivaracetam; | 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 |
10 |
Carbon monoxide
| 1件: Carbon monoxide Carbon monoxide | 1件: Carbon Monoxide Carbon Monoxide; | - | - | 8件: 6 6, 13, 53, 70, 85, 86, 149, 298 |
11 |
Triheptanoin
| 1件: Triheptanoin Triheptanoin | 1件: TRIHEPTANOIN TRIHEPTANOIN; | - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
12 |
Padsevonil
| 1件: Padsevonil Padsevonil | 1件: Padsevonil Padsevonil; | 3件: SV2A SV2A, SV2B, SV2C 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 149 149 |